Remed Co.Ltd (302550) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.026x

Based on the latest financial reports, Remed Co.Ltd (302550) has a cash flow conversion efficiency ratio of 0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.01 Billion ≈ $684.70K USD) by net assets (₩39.46 Billion ≈ $26.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Remed Co.Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Remed Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 302550 liabilities breakdown for a breakdown of total debt and financial obligations.

Remed Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Remed Co.Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
MGB Bhd
KLSE:7595
-0.059x
Ardiden Ltd
AU:ADV
-0.008x
TAPEX INC
KO:055490
0.003x
Asia File Corporation Bhd
KLSE:7129
0.035x
Formosa Prosonic Industries
KLSE:9172
0.009x
Quest For Growth - Pricaf
BR:QFG
-0.014x
Evergreen Corp
NASDAQ:EVGR
-0.024x
ad pepper media International N.V
XETRA:APM
0.095x

Annual Cash Flow Conversion Efficiency for Remed Co.Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of Remed Co.Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Remed Co.Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩39.46 Billion
≈ $26.74 Million
₩2.40 Billion
≈ $1.62 Million
0.061x +96.37%
2024-12-31 ₩40.25 Billion
≈ $27.28 Million
₩1.24 Billion
≈ $843.40K
0.031x -72.79%
2023-12-31 ₩30.79 Billion
≈ $20.87 Million
₩3.50 Billion
≈ $2.37 Million
0.114x -34.77%
2022-12-31 ₩29.92 Billion
≈ $20.28 Million
₩5.21 Billion
≈ $3.53 Million
0.174x +230.28%
2021-12-31 ₩26.10 Billion
≈ $17.69 Million
₩-3.49 Billion
≈ $-2.36 Million
-0.134x -227.93%
2020-12-31 ₩24.79 Billion
≈ $16.80 Million
₩2.59 Billion
≈ $1.76 Million
0.105x -20.14%
2019-12-31 ₩24.62 Billion
≈ $16.69 Million
₩3.22 Billion
≈ $2.18 Million
0.131x +550.48%
2018-12-31 ₩10.94 Billion
≈ $7.42 Million
₩-317.96 Million
≈ $-215.48K
-0.029x -282.16%
2017-12-31 ₩4.19 Billion
≈ $2.84 Million
₩66.75 Million
≈ $45.24K
0.016x --

About Remed Co.Ltd

KQ:302550 Korea Medical Devices
Market Cap
$64.62 Million
₩95.35 Billion KRW
Market Cap Rank
#20885 Global
#1282 in Korea
Share Price
₩3085.00
Change (1 day)
-0.16%
52-Week Range
₩2755.00 - ₩3985.00
All Time High
₩4180.00
About

Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells,… Read more